Investigation Trp64Arg polymorphism of the beta 3-adrenergic receptor gene in nonobese women with polycystic ovarian syndrome.

Beta-3 adrenergic receptor Codon 64 Polycystic ovarian syndrome. Polymorphism

Journal

International journal of reproductive biomedicine
ISSN: 2476-4108
Titre abrégé: Int J Reprod Biomed
Pays: Iran
ID NLM: 101679102

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 04 10 2018
revised: 12 05 2019
accepted: 03 10 2019
entrez: 21 4 2020
pubmed: 21 4 2020
medline: 21 4 2020
Statut: epublish

Résumé

Polycystic ovary syndrome (PCOS) is a multifactorial and heterogeneous disease that has a potent inheritable component based on familial clustering. Despite many studies in the genetic field of PCOS, the genes that are involved in the causes of this syndrome have not been thoroughly investigated. The purpose of this study was to establish the occurrence of the Trp64Arg polymorphism of beta3 adrenergic receptor in non-obese women with PCOS. This cross-sectional study was performed on 100 women with PCOS and normal women as the control group in Imam Khomeini Hospital of Tehran in 2016-2017. Peripheral blood sample (2 cc) was obtained from two groups for genomic DNA based on the gene bank. Polymorphisms were genotyped by of using ADRB3 Trp64Arg. Then the DNA was extracted by genomic kiagen kit. The primer was analyzed for PCR based on gene bank by using Primer3 software and then confirmed by primer Blast tool at NCBI site to conformity to the beta-3 adrenergic receptor gene. The protein changes were assessment by the Clastal W software. The sequence analysis presented in NCBI, transcript variant 1, with the code NM_000025.2, shows changes in the amino acid sequence of exon 1 in women with PCOS. Polymorphism in the codon 64 encoding the amino acid tryptophan (W) occurred in the nucleotide c.T190C, which changed the nucleotide T to C and then the amino acid sequence of the tryptophan was altered to arginine pW64R. T-C polymorphism is evident in the codon 64 of the adrenergic β3 receptor in patients with PCOS. Therefore, Beta3 adrenergic receptor gene polymorphism (Thr164Ile) associates with this syndrome in nonobese women.

Sections du résumé

BACKGROUND BACKGROUND
Polycystic ovary syndrome (PCOS) is a multifactorial and heterogeneous disease that has a potent inheritable component based on familial clustering. Despite many studies in the genetic field of PCOS, the genes that are involved in the causes of this syndrome have not been thoroughly investigated.
OBJECTIVE OBJECTIVE
The purpose of this study was to establish the occurrence of the Trp64Arg polymorphism of beta3 adrenergic receptor in non-obese women with PCOS.
MATERIALS AND METHODS METHODS
This cross-sectional study was performed on 100 women with PCOS and normal women as the control group in Imam Khomeini Hospital of Tehran in 2016-2017. Peripheral blood sample (2 cc) was obtained from two groups for genomic DNA based on the gene bank. Polymorphisms were genotyped by of using ADRB3 Trp64Arg. Then the DNA was extracted by genomic kiagen kit. The primer was analyzed for PCR based on gene bank by using Primer3 software and then confirmed by primer Blast tool at NCBI site to conformity to the beta-3 adrenergic receptor gene. The protein changes were assessment by the Clastal W software.
RESULTS RESULTS
The sequence analysis presented in NCBI, transcript variant 1, with the code NM_000025.2, shows changes in the amino acid sequence of exon 1 in women with PCOS. Polymorphism in the codon 64 encoding the amino acid tryptophan (W) occurred in the nucleotide c.T190C, which changed the nucleotide T to C and then the amino acid sequence of the tryptophan was altered to arginine pW64R.
CONCLUSION CONCLUSIONS
T-C polymorphism is evident in the codon 64 of the adrenergic β3 receptor in patients with PCOS. Therefore, Beta3 adrenergic receptor gene polymorphism (Thr164Ile) associates with this syndrome in nonobese women.

Identifiants

pubmed: 32309765
doi: 10.18502/ijrm.v18i3.6712
pmc: PMC7142317
doi:

Types de publication

Journal Article

Langues

eng

Pagination

165-174

Informations de copyright

Copyright © 2020 Zafari Zangeneh et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest.

Références

Fertil Steril. 2009 Feb;91(2):456-88
pubmed: 18950759
Immunol Invest. 2016 Oct;45(7):575-83
pubmed: 27603301
Curr Med Chem. 2006;13(1):25-37
pubmed: 16457637
Fertil Steril. 2004 Jan;81(1):19-25
pubmed: 14711538
Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E344-E358
pubmed: 28588096
Cardiol Rev. 2013 Nov-Dec;21(6):265-9
pubmed: 23707990
Ann N Y Acad Sci. 2010 Sep;1205:225-9
pubmed: 20840277
J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):42-52
pubmed: 20036327
Endocr Rev. 2012 Dec;33(6):981-1030
pubmed: 23065822
Diabetes. 2014 Apr;63(4):1270-82
pubmed: 24379345
Int J Reprod Biomed. 2017 Jun;15(6):375-382
pubmed: 29177240
Physiol Behav. 2004 Jul;81(5):781-93
pubmed: 15234184
Gynecol Endocrinol. 2017 Mar;33(3):227-233
pubmed: 27908212
Nat Rev Endocrinol. 2014 Jan;10(1):24-36
pubmed: 24146030
BMC Res Notes. 2011 May 27;4:167
pubmed: 21619577
J Clin Endocrinol Metab. 2001 May;86(5):1991-8
pubmed: 11344197
Reprod Biol Endocrinol. 2016 Jul 16;14(1):38
pubmed: 27423183
PLoS One. 2011;6(6):e21006
pubmed: 21701596
Front Genet. 2018 Apr 04;9:106
pubmed: 29670643
J Obstet Gynaecol. 2018 Feb;38(2):172-176
pubmed: 28783993
Obstet Gynecol Surv. 2008 Jan;63(1):39-48
pubmed: 18081939
Biochem J. 1997 Apr 15;323 ( Pt 2):359-64
pubmed: 9163324
Curr Opin Clin Nutr Metab Care. 2015 Jul;18(4):401-6
pubmed: 26049638
Vopr Pitan. 2012;81(2):23-7
pubmed: 22774474
Nature. 2008 Aug 21;454(7207):1000-4
pubmed: 18719589
Reprod Biomed Online. 2005 Jun;10(6):713-20
pubmed: 15969998
Genet Res Int. 2018 Feb 18;2018:7624932
pubmed: 29670770
Diabetologia. 1996 Mar;39(3):349-52
pubmed: 8721782
Mol Imaging. 2015;14(12):22-33
pubmed: 26637263
N Engl J Med. 1995 Sep 28;333(13):853-61
pubmed: 7651477
Cell Metab. 2015 Jan 6;21(1):33-8
pubmed: 25565203
Diabetes Metab. 1999 Mar;25(1):11-21
pubmed: 10335419
Am J Physiol Regul Integr Comp Physiol. 2002 Dec;283(6):R1321-6
pubmed: 12429558
Front Syst Neurosci. 2015 Nov 03;9:150
pubmed: 26578907
Int J Obes Relat Metab Disord. 1996 Mar;20(3):191-9
pubmed: 8653138
Diabetes Res Clin Pract. 2017 Jul;129:86-96
pubmed: 28521197
Metabolism. 2008 Oct;57(10):1422-7
pubmed: 18803948
Genes Immun. 2006 Jun;7(4):316-21
pubmed: 16691186
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
Am J Respir Cell Mol Biol. 1993 Mar;8(3):334-9
pubmed: 8383511
PLoS One. 2014 Jun 24;9(6):e100489
pubmed: 24960039
Diabetes. 2010 Jul;59(7):1789-93
pubmed: 20357363
Int J Obes (Lond). 2008 Aug;32(8):1240-9
pubmed: 18574485
Int J Obes (Lond). 2015 Mar;39(3):408-17
pubmed: 25189177
Endocrinology. 2006 Jan;147(1):31-8
pubmed: 16210362
Gynecol Endocrinol. 1996 Oct;10(5):357-64
pubmed: 8915666

Auteurs

Farideh Zafari Zangeneh (FZ)

Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Sarmast Shoushtari (MS)

Department of Chemical and Environment, Faculty of Engineering, UPM, Selangor, Malaysia.

Sahar Shojaee (S)

Cell Therapy Center, Gandhi Hospital, Tehran, Iran.

Elahe Aboutorabi (E)

Department of Genetics, Islamic Azad University Science and Research Branch, Tehran, Iran.

Classifications MeSH